| List Name |
Annotation |
Enrichment |
p-value |
| keratinocyte differentiation |
AmiGO Browser |
40.45 |
3.18e-06 |
| response to oxidative stress |
AmiGO Browser |
17.59 |
8.77e-05 |
| oxygen and reactive oxygen species metabolic process |
AmiGO Browser |
13.37 |
2.52e-04 |
| regulation of exocytosis |
AmiGO Browser |
42.58 |
1.02e-03 |
| calcium ion-dependent exocytosis |
AmiGO Browser |
31.12 |
1.91e-03 |
| electron transport |
AmiGO Browser |
4.78 |
4.34e-03 |
| heart development |
AmiGO Browser |
6.82 |
0.01 |
| induction of apoptosis by oxidative stress |
AmiGO Browser |
80.91 |
0.01 |
| activation of MAPK activity |
AmiGO Browser |
11.90 |
0.01 |
| positive regulation of MAPK activity |
AmiGO Browser |
10.24 |
0.02 |
| negative regulation of cyclin-dependent protein kinase activity |
AmiGO Browser |
50.57 |
0.02 |
| B cell homeostasis |
AmiGO Browser |
50.57 |
0.02 |
| MAPKKK cascade |
AmiGO Browser |
5.30 |
0.02 |
| sensory perception of light stimulus |
AmiGO Browser |
5.12 |
0.02 |
| visual perception |
AmiGO Browser |
5.12 |
0.02 |
| generation of precursor metabolites and energy |
AmiGO Browser |
3.13 |
0.02 |
| ubiquinone metabolic process |
AmiGO Browser |
40.45 |
0.02 |
| quinone cofactor biosynthetic process |
AmiGO Browser |
40.45 |
0.02 |
| ubiquinone biosynthetic process |
AmiGO Browser |
40.45 |
0.02 |
| negative regulation of B cell activation |
AmiGO Browser |
36.78 |
0.03 |
| quinone cofactor metabolic process |
AmiGO Browser |
36.78 |
0.03 |
| protein targeting to peroxisome |
AmiGO Browser |
33.71 |
0.03 |
| synaptic vesicle exocytosis |
AmiGO Browser |
33.71 |
0.03 |
| T cell homeostasis |
AmiGO Browser |
33.71 |
0.03 |
| peroxisomal transport |
AmiGO Browser |
31.12 |
0.03 |
| spinal cord development |
AmiGO Browser |
28.90 |
0.03 |
| exocytosis |
AmiGO Browser |
6.86 |
0.03 |
| DNA fragmentation during apoptosis |
AmiGO Browser |
26.97 |
0.04 |
| regulation of MAPK activity |
AmiGO Browser |
6.63 |
0.04 |
| sensory perception |
AmiGO Browser |
3.21 |
0.04 |
| regulation of B cell proliferation |
AmiGO Browser |
25.28 |
0.04 |
| regulation of protein kinase activity |
AmiGO Browser |
4.05 |
0.04 |
| hemopoiesis |
AmiGO Browser |
4.01 |
0.04 |
| regulation of kinase activity |
AmiGO Browser |
3.98 |
0.04 |
| regulation of transferase activity |
AmiGO Browser |
3.97 |
0.04 |
| negative regulation of endothelial cell proliferation |
AmiGO Browser |
23.80 |
0.04 |
| regulation of activated T cell proliferation |
AmiGO Browser |
23.80 |
0.04 |
| adrenal gland development |
AmiGO Browser |
22.47 |
0.04 |
| induction of apoptosis via death domain receptors |
AmiGO Browser |
22.47 |
0.04 |
| regulation of transport |
AmiGO Browser |
5.95 |
0.05 |
| negative regulation of T cell proliferation |
AmiGO Browser |
21.29 |
0.05 |
| lymphocyte homeostasis |
AmiGO Browser |
21.29 |
0.05 |
| traversing start control point of mitotic cell cycle |
AmiGO Browser |
21.29 |
0.05 |
| hemopoietic or lymphoid organ development |
AmiGO Browser |
3.76 |
0.05 |
| DNA-dependent DNA replication |
AmiGO Browser |
5.78 |
0.05 |
| homeostasis of number of cells |
AmiGO Browser |
19.26 |
0.05 |
| leukocyte homeostasis |
AmiGO Browser |
19.26 |
0.05 |
| release of cytochrome c from mitochondria |
AmiGO Browser |
18.39 |
0.05 |
| cell structure disassembly during apoptosis |
AmiGO Browser |
18.39 |
0.05 |
| apoptotic nuclear changes |
AmiGO Browser |
18.39 |
0.05 |
| negative regulation of T cell activation |
AmiGO Browser |
18.39 |
0.05 |
| protein kinase cascade |
AmiGO Browser |
2.86 |
0.05 |
| regulation of osteoclast differentiation |
AmiGO Browser |
17.59 |
0.06 |
| activation of JNK activity |
AmiGO Browser |
17.59 |
0.06 |
| positive regulation of JNK activity |
AmiGO Browser |
17.59 |
0.06 |
| regulation of endothelial cell proliferation |
AmiGO Browser |
17.59 |
0.06 |
| immune system development |
AmiGO Browser |
3.51 |
0.06 |
| activated T cell proliferation |
AmiGO Browser |
16.86 |
0.06 |
| DNA catabolic process |
AmiGO Browser |
16.86 |
0.06 |
| regulation of developmental process |
AmiGO Browser |
3.34 |
0.06 |
| apoptotic mitochondrial changes |
AmiGO Browser |
15.56 |
0.06 |
| G2/M transition of mitotic cell cycle |
AmiGO Browser |
15.56 |
0.06 |
| negative regulation of lymphocyte proliferation |
AmiGO Browser |
15.56 |
0.06 |
| negative regulation of mononuclear cell proliferation |
AmiGO Browser |
15.56 |
0.06 |
| regulation of catalytic activity |
AmiGO Browser |
2.69 |
0.06 |
| response to chemical stimulus |
AmiGO Browser |
2.68 |
0.06 |
| B cell proliferation |
AmiGO Browser |
14.98 |
0.06 |
| endothelial cell proliferation |
AmiGO Browser |
14.45 |
0.07 |
| osteoclast differentiation |
AmiGO Browser |
14.45 |
0.07 |
| positive regulation of protein kinase activity |
AmiGO Browser |
4.70 |
0.07 |
| regulation of progression through cell cycle |
AmiGO Browser |
2.31 |
0.07 |
| synaptic vesicle transport |
AmiGO Browser |
13.95 |
0.07 |
| regulation of cell cycle |
AmiGO Browser |
2.30 |
0.07 |
| positive regulation of transferase activity |
AmiGO Browser |
4.62 |
0.07 |
| mRNA catabolic process, nonsense-mediated decay |
AmiGO Browser |
13.48 |
0.07 |
| response to reactive oxygen species |
AmiGO Browser |
13.48 |
0.07 |
| regulation of MAPKKK cascade |
AmiGO Browser |
13.48 |
0.07 |
| regulation of JNK activity |
AmiGO Browser |
13.48 |
0.07 |
| gluconeogenesis |
AmiGO Browser |
13.05 |
0.07 |
| regulation of a molecular function |
AmiGO Browser |
2.54 |
0.07 |
| membrane organization and biogenesis |
AmiGO Browser |
3.08 |
0.08 |
| pyruvate metabolic process |
AmiGO Browser |
12.64 |
0.08 |
| response to UV |
AmiGO Browser |
12.64 |
0.08 |
| peroxisome organization and biogenesis |
AmiGO Browser |
12.26 |
0.08 |
| negative regulation of cell migration |
AmiGO Browser |
12.26 |
0.08 |
| negative regulation of lymphocyte activation |
AmiGO Browser |
11.90 |
0.08 |
| gene silencing |
AmiGO Browser |
11.90 |
0.08 |
| DNA metabolic process |
AmiGO Browser |
2.19 |
0.08 |
| vesicle-mediated transport |
AmiGO Browser |
2.47 |
0.08 |
| neurological process |
AmiGO Browser |
2.16 |
0.08 |
| G1 phase of mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
| negative regulation of locomotion |
AmiGO Browser |
10.93 |
0.09 |
| negative regulation of cell motility |
AmiGO Browser |
10.93 |
0.09 |
| regulation of DNA replication |
AmiGO Browser |
10.65 |
0.09 |
| regulation of B cell activation |
AmiGO Browser |
10.65 |
0.09 |
| hexose biosynthetic process |
AmiGO Browser |
10.37 |
0.09 |
| regulation of axonogenesis |
AmiGO Browser |
10.37 |
0.09 |
| monosaccharide biosynthetic process |
AmiGO Browser |
10.37 |
0.09 |
| alcohol biosynthetic process |
AmiGO Browser |
10.37 |
0.09 |
| regulation of myeloid leukocyte differentiation |
AmiGO Browser |
10.11 |
0.09 |
| G1 phase |
AmiGO Browser |
10.11 |
0.09 |
| positive regulation of transcription |
AmiGO Browser |
2.76 |
0.10 |
| mRNA catabolic process |
AmiGO Browser |
9.87 |
0.10 |
| nuclear organization and biogenesis |
AmiGO Browser |
9.63 |
0.10 |
| oxidoreduction coenzyme metabolic process |
AmiGO Browser |
9.41 |
0.10 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.70 |
0.10 |
| DNA replication initiation |
AmiGO Browser |
9.19 |
0.10 |
L2L Microarray Analysis Tool